TEM Tempus AI, Inc. NASDAQ · Not recorded

Tempus AI (TEM) news TEM offering and convertible notes news

Debt Financing · May 12, 2026

Tempus AI completes $460.0 million convertible notes offering

The notes carry no regular interest and mature May 15, 2032, after the initial purchasers exercised their option in full.

Latest Tempus AI news

We have not published a story on Tempus AI yet. When there is news, it will appear here.

Questions about Tempus AI

Has Tempus AI raised money recently?

Our latest story on this, dated May 12, 2026: "Tempus AI completes $460.0 million convertible notes offering". The story links the filing or release it is based on. Read the story.

Has Tempus AI sold convertible notes?

Our latest story on this, dated May 12, 2026: "Tempus AI completes $460.0 million convertible notes offering". The story links the filing or release it is based on. Read the story.

What is the ticker symbol of Tempus AI?

Tempus AI, Inc. trades under the ticker TEM on NASDAQ.

Where is Tempus AI listed?

Tempus AI, Inc. is listed on NASDAQ.

Which country or territory is Tempus AI listed under?

Our directory records Tempus AI, Inc. under Not recorded.

Does aibio.space cover Tempus AI?

aibio.space lists Tempus AI, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What is the latest Tempus AI (TEM) stock news?

Our latest story on Tempus AI, dated May 12, 2026: "Tempus AI completes $460.0 million convertible notes offering". The notes carry no regular interest and mature May 15, 2032, after the initial purchasers exercised their option in full. Source.

How can I follow Tempus AI (TEM) news?

Press Follow on this page to add Tempus AI to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Tempus AI so far, in Debt Financing.

Investor discussion: Tempus AI

Members talk about Tempus AI (TEM). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:TEM on TradingView.

Listing details

Tempus AI, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TEM, recorded under Not recorded. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company: Tempus AI, Inc.
Ticker: TEM
Listing: NASDAQ
Country or territory: Not recorded

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction